This inventor holds 2 USPTO granted patents. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Mitsuo Umemoto: Innovator in Pharmaceutical Formulations
Introduction
Mitsuo Umemoto is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of prolonged-release formulations. With a total of 2 patents, his work has had a meaningful impact on the pharmaceutical industry.
Latest Patents
Umemoto's latest patents include a prolonged-release liquid type of pharmaceutical preparation. This innovative formulation involves coating a pharmaceutically active drug-ion exchange resin complex with a water-permeable diffusion barrier material. The result is a stable preparation that maintains controlled release of the active ingredient, even in solutions containing preservatives. Another significant patent is a pharmaceutical formulation in the form of an aqueous suspension. This formulation includes an ion exchange resin carrying an active ingredient and a suspending agent, enhanced by the addition of a basic or neutral amino acid or its salt as a dispersion stabilizer.
Career Highlights
Throughout his career, Umemoto has worked with prominent companies in the pharmaceutical sector, including Rohto Pharmaceutical Co., Ltd. His expertise in pharmaceutical formulations has positioned him as a key figure in the development of innovative drug delivery systems.
Collaborations
Umemoto has collaborated with notable colleagues such as Youko Mitani and Kiyotsugu Higashi. Their combined efforts have contributed to advancements in pharmaceutical technology and formulation science.
Conclusion
Mitsuo Umemoto's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of formulation science, making him a valuable asset to the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
